Key result
XLalphas B allele shows no association with thrombotic or haemorrhagic disorders.
Why the study?
A polymorphism of the gene encoding XLalphas was identified in patients with bleeding tendency, prompting investigation of its genetic, functional, and clinical relevance in thrombotic and haemorrhagic disorders.
Does the XLalphas polymorphism increase the risk of thrombotic or haemorrhagic disorders?
Case-Control (n=976)
Does the XLalphas polymorphism increase the risk of thrombotic or haemorrhagic disorders?
The XLalphas polymorphism appears to have a minor functional role and does not significantly affect the risk of thrombotic or haemorrhagic disorders in the Mediterranean population.
Answers are grounded in this paper and cite their sources.
XLalphas B allele shows no risk association in this Mediterranean cohort; leaves open relevance in other populations or disorders.
A polymorphism of the gene encoding the extra-large stimulatory G-protein alpha-subunit (XLalphas), originally identified in three patients with a bleeding tendency, involved a 36-bp insertion and two missense changes. A paternally-inherited insertion displayed a moderate platelet Gsalpha over-expression, which lead to platelet hypo-reactivity. These data prompted us to investigate the genetic, functional and clinical relevance of this polymorphism in the Mediterranean population. We included 414 healthy subjects and three case/control studies: 263 consecutive patients with a first episode of primary intracerebral haemorrhage, 195 patients with deep venous thrombosis, and 104 patients with cerebrovascular disease. Controls were selected by approximating criteria to match selected risk factors to patients. Moreover, we performed studies of platelet function. We developed a simple method to determine the methylated allele, by digestion of genomic DNA with Sma I before polymerase chain reaction amplification. We identified two new rare variants, resulting from the loss of repeat units 7 and 5. The AB genotype was present in 3.6% of healthy population and the prevalence of the B allele was similar among cases and controls. Accordingly, the non-methylated B allele did not modify either the expression of platelet Gsalpha or the platelet response to Gs-agonists. Thus, our study suggests a minor functional role of XLalphas polymorphism in thrombotic or in haemorrhagic disorders.
No takes yet. Share an insight, caveat, or question.
Gónzález‐Conejero et al. (2004) conducted a case-control in Thrombotic and haemorrhagic disorders (n=976). XLalphas polymorphism vs. Controls was evaluated on Prevalence of the B allele. The XLalphas polymorphism B allele had a similar prevalence among cases and controls, suggesting a minor functional role in thrombotic or haemorrhagic disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: